marijuana stocks

Thanks for The Update Bill!

Creative Edge Nutrition, Inc. (PINKSHEETS: FITX) updated shareholders today on recent company developments.

Their partially owned subsidiary, CEN Biotech Inc. was asked not to attend the Town of Lakeshore’s latest meeting. During the meeting, a resolution was passed and the town issued a letter to Health Canada asking them to hold off on issuing a license for FITX’s facility. FITX believes that this resolution being passed contradicts the support that they have received from the town over the past year.

Creative Edge Nutrition is focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. They are partial owners of CEN Biotech, Inc., who is focused on supplying the Canadian public with pharmaceutical-grade medical cannabis under the Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted an application to become a licensed producer and has received already-to-build approval from Health Canada.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 AgraFlora Organics International Inc. (AGFAF) Receives Standard Cultivation License from Health Canada

AgraFlora’s Delta Greenhouse Facility Receives Standard Cultivation License from Health Canada  AgraFlora…

$CBSI Interview US Surgeon General Believes Medical Cannabis Can Be Helpful

Cannabis Science Reports ‘CBS This Morning’ Interview; US Surgeon General Believes Medical…

Jushi Holdings Inc. (JUSHF) Further Expands Nevada Footprint Through Agreement

Jushi Holdings Inc. Further Expands Nevada Footprint Through Agreement to Acquire Vertically…

GT Biopharma Announces Update To OXS-3550 IND Filing, Its Most Advanced Tri-Specific Killer Engager

LOS ANGELES, CA, May 16, 2018 – GT Biopharma Inc. (OTCQB: GTBP…